Overview

A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Status:
Not yet recruiting
Trial end date:
2023-10-11
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate safety of dulaglutide in participants with type 2 diabetes mellitus in India.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Dulaglutide